Osteomyelitis and arthritis caused by mucormycetes are rare diseases that rank among the most challenging complications in orthopedic and trauma surgery. The aim of this work is to review the epidemiological, clinical, diagnostic, and therapeutic aspects of the osteoarticular mucormycosis with particular emphasis on high-risk patients. A systematic review of osteoarticular mucormycosis was performed using PUBMED and EMBASE C The Author 2017. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
databases from 1978 to 2014. Among 34 patients with median age 41 (0.5-73 years), 24 
Introduction
Fungi that belong to the order Mucorales comprise predominantly naturally occurring saprotrophs that inhabit soil and decomposing matter. 1 While most of the fungi within the order Mucorales are seldom involved in human infections, the incidence of life-threatening disease caused by several species is increasing in hosts with severe immune or metabolic impairment, hematological malignancy, hematopoietic stem cell transplantation, and uncontrolled ketoacidosis diabetes mellitus. [2] [3] [4] [5] Infections often take a dramatic course with unfavorable prognosis and mortality due to deeply invasive, and disseminated disease in patients with immunodeficiencies. 6 Osteoarticular mycoses are uncommon diseases. During the past several years, several major systematic reviews have elucidated the key demographic, diagnostic, therapeutic, and outcome variables of many of the osteoarticular mycoses. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] However, there remains to be completed a comprehensive analysis focused exclusively on osteoarticular mucormycosis. We therefore undertook a systematic review of the epidemiological, clinical, diagnostic, and therapeutic aspects of these serious infections with particular emphasis on the net state of immunosuppression, the effect of age, different routes of infection, anatomical distribution, and outcome.
Methods

Search criteria
In order to identify fungal osteomyelitis and arthritis caused by Mucormycetes, we used the OvidSP search platform in MEDLINE and EMBASE databases from 1978 to 2014, using the following keywords: fungi, Rhizopus, Apophysomyces, Mucor, Cunninghamella, Lichtheimia (formerly Absidia), Saksenaea, Zygomycetes, zygomycosis, mucormycosis, systemic mycosis, bone diseases, bone infection, osteitis, osteomyelitis, periostitis, spondylitis, discitis, osteochondritis, osteomyelitis, periostitis, infectious arthritis, bone and joint infections, and reactive arthritis We included cases in the final analysis for the years 1978-2014 with data on osteomyelitis and or arthritis, site of infection, underlying disease, antifungal therapy, and surgical intervention. Among other parameters considered in the case analysis were diagnostic images, inflammatory markers, and disease manifestations. We excluded cases with bone extension from rhinosinusitis, cases with missing full texts, and cases of non-English literature.
Data extraction
The following parameters were extracted from each study when present: age, sex, risk factors, prior surgery, treatment, antifungal agent, duration of treatment, time to diagnosis, fever, inflammatory markers, neutropenia, radiological features, type of bone infection, surgical intervention, histopathology, microscopy, culture, fungal species, and outcomes.
Terminology and definitions
There are different classification systems by which to classify osteomyelitis. 18 Descriptive terms were applied to mechanisms of bone infection, criteria for diagnostic probability, onset of disease, and histopathologic characteristics of osteomyelitis. All definitions used throughout this study were utilized in previous studies of osteoarticular mycoses: [10] [11] [12] [13] [14] [15] [16] [17] Direct inoculation: local bone or joint infection following a breach of cutaneous integrity;
Hematogenous: seeding of bone or joint by dissemination from a distant site of inoculation and/or infection;
Contiguous: describes the seeding of bone or joint from an adjacent site of infection; Proven fungal osteomyelitis: evidence of a positive culture and/or histology from bone tissue, joint fluid, or metal hardware; Probable fungal osteomyelitis: compatible clinical and radiological features of osteomyelitis with evidence of positive histology and/or fungal culture from an extraosteoarticular site;
Complete response: resolution of clinical and radiological findings of osteomyelitis; Partial response: incomplete resolution of clinical, and/or radiological findings of osteomyelitis, or incomplete clinical improvement without the availability of radiological data;
Overall response: complete or partial response of clinical and radiological findings of osteomyelitis;
Pediatric patients: patients who were ≤15 years; Elevated white blood cell (WBC) count: >10,000/μl.
Data analysis and statistical methods
Descriptive statistics were used to summarize all demographic and clinical characteristics of the patients. The quality of data (review of completeness, data verification, validation) was assured by the lead investigator (SJT). All statistical analyses were performed using statistical packages SPSS 19.0 (SPSS Inc. Chicago, IL).
Results
Identification of cases
A total of 34 individual cases from 30 publications (Table 1 ) of osteoarticular infections fulfilled the prespecified definition criteria. Cases were classified as proven in 82% (n = 28) with positive hyphae in histopathology sections, and probable in 18% (n = 6) in which histopathology was not performed.
Etiology
The most common pathogens of the Mucorales that caused bone and joint infections were Rhizopus species (15 cases) [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] followed by Apophysomyces elegans (four cases) [30] [31] [32] [33] , Mucor species (three cases), [34] [35] [36] Cunninghamella bertholletiae (two cases), 37, 38 and one case for each Lichtheimia (formerly Absidia) corymbifera 39 and Saksenaea vasiformis. 40 A genus was not specified in eight cases of histologically documented mucormycosis. [41] [42] [43] [44] [45] [46] [47] [48] All patients were infected with one fungal species.
Patient population and comorbidities
The demographic characteristics of the 34 patients are described in Table 2 . Among the 34 patients with bone and joint infection, male subjects predominated (71%). The disease was more responsible for osteomyelitis in adults (≥15 years). Among the underlying conditions in immunocompetent patients were trauma, vehicular accidents with fracture, and puncture of the knee or penetrating wounds. The underlying conditions identified for the majority of patients included prior surgery (41%), trauma (21%), corticosteroids (21%), and diabetes mellitus (18%). Severely immunocompromised patients including those with hematological malignancies, bone marrow/stem cell transplantation, solid organ transplantation, and HIV/AIDS, accounted for 35% of cases.
Clinical manifestation and mechanisms of infection
The most frequently reported clinical manifestations were restricted movements (62%), local pain, tenderness, and/or swelling (59%), and cellulitis/abscess (24%) ( Table 3) . Fever was seldom reported. Elevated inflammatory markers were detected for ESR and WBC; data for C-reactive protein was not available. Direct inoculation was the main mechanism of infection in 56% of cases, especially in patients subjected to prior trauma, accident, or previous surgery. Hematogenous dissemination occurred in 24% of cases, particularly in patients with hematological malignancy and other immune impairments. Contiguous spread was observed in the remaining 21%.
Diagnostic procedures
Open surgical wounds were the main biopsy procedure of most (87.5%) reported cases. The median diagnostic delay from onset of symptoms and signs in all cases of mucormycetes bone and joint infections was 60 (10-180) days (Table 3) . Table 1 . Cases of mucormycetes bone and joint infection .
No.
Ref
Age/ sex
Culture results 
Predisposing factors
Site of infection
Hyphae in
Diagnostic imaging
Osteoarticular abnormalities detected by different diagnostic imaging modalities included osteolytic lesions, bone destruction/erosion, lucencies, and increase of radionuclide uptake (Table 3) . Magnetic resonance imaging demonstrated low signal intensity on T1 weighted and patches of high signal intensity on T2 weighted images.
Treatment and outcome
Patients with osteoarticular mucormycosis were usually managed with combined medical and surgical intervention. Surgical intervention and/or medical therapy was reported in 33 (97%) of 34 patients (Table 3) . Among the 33 patients who received treatment, most patients 28 (85%) were managed with a combination of antifungal therapy and surgery, four (12%) with antifungal agents, and one (3%) with surgical treatment only. One patient died before initiation of any therapeutic intervention. All cases were treated with amphotericin B. Posaconazole was used as maintenance therapy after amphotericin B treatment in 4 cases. The median duration of medical treatment was 45 (5-573) days. Debridement was the most frequent surgical intervention (38%) followed by bone grafting/fixation procedures (21%), amputation (15%), and full excision (15%) ( Table 3 ). An overall response rate of 76% was achieved in the treatment of 34 mucormycetes bone and joint infection with complete response in 41% and partial response in 35%. One patient died before treatment could be initiated. Overall mortality rate was 24% with 6 (75%) of these deaths attributable to advanced bone infection and treatment failure with amphotericin B, while two were related to progressive risk factors and infection (Table 3) .
Discussion
The majority of cases of osteoarticular mycoses are caused by Aspergillus 11, 14, 16 and Candida species. 8, 10, 13 Other osteoarticular mycoses are caused by dimorphic fungi, which demonstrate distinctive clinical presentations, emerge in endemic areas, occur predominantly in immunocompetent patients, and develop from hematogenous dissemination.
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Most of these infections present with an indolent clinical course. Osteoarticular mucormycosis, by comparison, is relentlessly progressive with soft tissue compromise and bone destruction that may necessitate extremity amputation. 19, 34 While mucormycosis is highly aggressive and destructive in lung, sinuses, and brain, it is more indolent in bone with average time to diagnosis of 73 days, The destructive nature of Mucormycetes as causative pathogens of osteomyelitis, in addition to specific risk factors and underlying conditions associated with these pathogens, represent a formidable challenge to clinicians due to limited treatment options, and comparatively high directly related mortality compared to that of osteoarticular infections caused by other fungi. An important characteristic of these polymorphic infections is the fact that mucormycosis can infect a wide variety of bones and joints with no real predilection of the site of infection. The site depends on the mechanism of infection, affecting the long bones after trauma or surgery, or a wide variety of bones after hematogenous dissemination. That 56% of cases were caused by direct inoculation rather than involving the respiratory tract or causing disseminated disease likely accounts for the lower mortality in osteoarticular mucormycosis when compared to those in more lethal pulmonary, sino-orbital, and rhinocerebral forms of these infections, which approach 80%, depending upon species. 6 As with Aspergillus, 11, 14, 16 Candida, 10, 13 and other nonAspergillus moulds, 17 osteoarticular infections, there is a high male predominance with >2:1 male-to-female ratio in cases of mucormycosis of the bones and joints. Two main pathogenic mechanisms of infection were observed in immunocompetent patients. The first one was a communityacquired infection by direct inoculation during trauma, and the second one was a healthcare-associated infection after surgical procedures. Hematogenous dissemination was especially observed in patients with hematological malignancy or who were otherwise immunocompromised. Unlike Candida osteoarticular infections, which were reported as a result of hematogenous spread, 10 direct inoculation is the cause of infection for the majority (56%) of mucormycosis reported herein. A definitive diagnosis of osteoarticular mucormycosis was delayed by a median of 60 days from the onset of symptoms and signs. Contributing to this delay is the paucity of fever in most cases, while elevated inflammatory markers (ESR, WBC) were nonspecifically elevated. Localized pain, tenderness, and swelling should prompt diagnostic imaging, which then lead to biopsy if imaging is compatible with osteoarticular infection.
The diagnostic imaging features of the osteolytic lesion, bone destruction/erosion, and MRI T 2 weighted signal intensity are compatible with infection process but not characteristic for mucormycetes. Thus, evaluation of suspected mucormycetes infection of bone and joint should include biopsy for culture and histopathology, as well as visualization of the distinct ribbon-like hyphae in the clinical specimen using fluorescent dye.
Osteoarticular mucormycosis constitutes a serious diagnostic and therapeutic challenge. Despite antifungal treatment and surgical intervention, mortality was 24%, which is higher than the values previously reported to other fungal osteoarticular infections 12, 17 but less than percentage mortality for Aspergillus osteomyelitis.
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As reflected in the 85% of patients in this report, surgical intervention combined with antifungal therapy is widely considered an important treatment option of mucormycetes osteomyelitis and joint infections. Debridement of the infected tissues and bone excision were the primary surgical strategies applied for local control in mucormycete osteomyelitis. Some patients had bone reconstruction with allograft. 20 Synovectomy and prosthetic joint replacement were used in the surgical management of septic arthritis. These bone reconstructions were performed during a second operation, several weeks or months after debridement. Bone grafting and autotransplantation, were the leading interventional procedures used for reconstruction mucormycetes osteoarticular infections. The delay between radical debridement and reconstruction was at least six months and 9.6 months at median 20 in order to avoid secondary infection of the graft. This delayed bone repair and reconstruction may be essential to control the relapse of the disease in the transplanted reconstruction material. Similarly, within other mould osteoarticular infections, the majority of patients with Aspergillus (67%) and nonAspergillus (69%) osteoarticular infections received antifungal therapy plus surgery. 11, 17 By comparison, 48% of patients with Candida osteoarticular infections were treated with combined antifungal and surgical intervention. 10 Therapeutic success in osteoarticular mucormycosis depends on early diagnosis, the etiologic agent, severity of infection, underlying host factors, comorbidities, as well as type and location of infected bone. For example, the osteoarticular infection caused by A. elegans with ≥3 types of bones led to unfavorable prognosis 30 or amputation. 33 Among 34 cases of bone and joint infections due to mucormycosis, medical therapy in all cases consisted of an AmB formulation with eight having an unfavorable outcome. Amphotericin B is the primary agent for treatment of mucromycetous infections of bone and joint tissue. There are no controlled studies to support combinations of antifungal therapy of osteoarticular mucormycosis. Guidelines for the treatment of osteoarticular mucormycosis require antifungal therapy with amphotericin B and surgical intervention in most cases. In ESCMID and ECCM joint guidelines, 49 liposomal amphotericin B is recommended as the principal first-line agent for treatment of mucormycosis. Although salvage therapy with posaconazole for the treatment of mucormycosis has been reported, 50, 51 it is not recommended as primary therapy. In this study, posaconazole was used as a maintenance therapy in the treatment of four patients, one of who died. Whether isavuconazole, which was recently introduced for the primary treatment of mucormycosis, 52 has a role in the management of osteoarticular mucormycosis warrants further study. Reversal of primary immune impairments, including recovery from neutropenia, withdrawal of corticosteroids, and reversal of metabolic derangements in diabetes mellitus are essential to successful management of osteoarticular mucormycosis. In summary, the standards of current management of this debilitating and potentially lethal infection remain early diagnosis, liposomal amphotericin B, surgical resection, and reversal of host defects.
